Menu Search
Equities

Daito Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
DAITF:PKL

Daito Pharmaceutical Co Ltd

Actions
  • Price (USD)13.13
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta0.7007
Data delayed at least 15 minutes, as of Jan 03 2025.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Daito Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture, sale, purchase and sale of active pharmaceutical ingredients and formulations (prescription drugs and over-the-counter drugs), contract manufacturing of active pharmaceutical ingredients and formulations, and sale of health foods and other products. The Company is primarily engaged in the pharmaceutical business segment. The main products are active pharmaceutical ingredients and formulations. The Company manufactures, sells, purchases and sells active pharmaceutical ingredients, which are raw materials used to manufacture pharmaceuticals, and undertakes contract manufacturing. The Company also manufactures, sells, purchases and sells formulations of prescription drugs and over-the-counter drugs, and undertakes contract manufacturing.

  • Revenue in JPY (TTM)51.20bn
  • Net income in JPY2.23bn
  • Incorporated1942
  • Employees1.07k
  • Location
    Daito Pharmaceutical Co Ltd326, Yoka-machiTOYAMA-SHI 939-8567JapanJPN
  • Phone+81 764215665
  • Fax+81 764216006
  • Websitehttps://www.daitonet.co.jp/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.